{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T18:20:13Z","timestamp":1777054813139,"version":"3.51.4"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2016,12,29]],"date-time":"2016-12-29T00:00:00Z","timestamp":1482969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA 134051"],"award-info":[{"award-number":["R01 CA 134051"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005627","name":"Thrasher Research Fund","doi-asserted-by":"publisher","award":["9135"],"award-info":[{"award-number":["9135"]}],"id":[{"id":"10.13039\/100005627","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005627","name":"Thrasher Research Fund","doi-asserted-by":"publisher","award":["12289"],"award-info":[{"award-number":["12289"]}],"id":[{"id":"10.13039\/100005627","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA189806"],"award-info":[{"award-number":["R01CA189806"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Naval Medical Center","award":["HT9404-13-1-0022"],"award-info":[{"award-number":["HT9404-13-1-0022"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0167841","type":"journal-article","created":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T20:35:14Z","timestamp":1483994114000},"page":"e0167841","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Regulatory T Cells in Endemic Burkitt Lymphoma Patients Are Associated with Poor Outcomes: A Prospective, Longitudinal Study"],"prefix":"10.1371","volume":"11","author":[{"given":"Emily","family":"Parsons","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana A.","family":"Otieno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John Michael","family":"Ong\u2019echa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina E.","family":"Nixon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Vulule","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"M\u00fcnz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. Ann","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann M.","family":"Moormann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,12,29]]},"reference":[{"issue":"7","key":"ref1","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1470-2045(08)70175-X","article-title":"Part I: Cancer in Indigenous Africans\u2014burden, distribution, and trends","volume":"9","author":"DM Parkin","year":"2008","journal-title":"Lancet Oncol"},{"issue":"6","key":"ref2","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/j.1365-2141.2011.09013.x","article-title":"Epidemiology: clues to the pathogenesis of Burkitt lymphoma","volume":"156","author":"I Magrath","year":"2012","journal-title":"Br J Haematol"},{"issue":"6","key":"ref3","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1046\/j.1525-1381.1999.t01-1-99220.x","article-title":"Epstein-Barr virus: the first human tumor virus and its role in cancer","volume":"111","author":"JS Pagano","year":"1999","journal-title":"Proceedings of the Association of American Physicians"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/ijc.2910220305","article-title":"Primary Epstein-Barr virus infections in African infants. II. Clinical and serological observations during seroconversion","volume":"22","author":"RJ Biggar","year":"1978","journal-title":"Int J Cancer"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1086\/511984","article-title":"Exposure to holoendemic malaria results in suppression of Epstein-Barr virus-specific T cell immunosurveillance in Kenyan children","volume":"195","author":"AM Moormann","year":"2007","journal-title":"The Journal of infectious diseases"},{"issue":"6","key":"ref6","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1371\/journal.ppat.0030080","article-title":"A molecular link between malaria and Epstein-Barr virus reactivation","volume":"3","author":"A Chene","year":"2007","journal-title":"PLoS pathogens"},{"issue":"12","key":"ref7","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.4049\/jimmunol.170.12.6183","article-title":"Regulatory T cells secreting IL-10 dominate the immune response to EBV latent membrane protein 1","volume":"170","author":"NA Marshall","year":"2003","journal-title":"Journal of immunology"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1158\/0008-5472.CAN-04-2552","article-title":"Functional characterization of EBV-encoded nuclear antigen 1-specific CD4+ helper and regulatory T cells elicited by in vitro peptide stimulation","volume":"65","author":"KS Voo","year":"2005","journal-title":"Cancer research"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2141.2007.06765.x","article-title":"CD4(+) T-cell responses to Epstein-Barr virus (EBV) latent membrane protein 1 in infectious mononucleosis and EBV-associated non-Hodgkin lymphoma: Th1 in active disease but Tr1 in remission","volume":"139","author":"NA Marshall","year":"2007","journal-title":"Br J Haematol"},{"issue":"Pt 7","key":"ref10","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1099\/0022-1317-71-7-1481","article-title":"Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line","volume":"71","author":"CD Gregory","year":"1990","journal-title":"The Journal of general virology"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood-2003-07-2594","article-title":"Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma","volume":"103","author":"NA Marshall","year":"2004","journal-title":"Blood"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1182\/blood.V86.4.1493.bloodjournal8641493","article-title":"Local suppression of Epstein-Barr virus (EBV)-specific cytotoxicity in biopsies of EBV-positive Hodgkin's disease","volume":"86","author":"T Frisan","year":"1995","journal-title":"Blood"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.virol.2013.03.016","article-title":"Therapeutic targeting of regulatory T cells enhances tumor-specific CD8+ T cell responses in Epstein-Barr virus associated nasopharyngeal carcinoma","volume":"441","author":"M Fogg","year":"2013","journal-title":"Virology"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/ijc.25429","article-title":"Regulatory T cells in tumor immunity","volume":"127","author":"H Nishikawa","year":"2010","journal-title":"Int J Cancer"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/sj.bjc.6603580","article-title":"Increase in circulating Foxp3+CD4+CD25(high) regulatory T cells in nasopharyngeal carcinoma patients","volume":"96","author":"KM Lau","year":"2007","journal-title":"Br J Cancer"},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1007\/s12032-012-0299-4","article-title":"Increased expression of CD4+CD25 +FOXP3+ regulatory T cells correlates with Epstein-Barr virus and has no impact on survival in patients with classical Hodgkin lymphoma in Brazil","volume":"29","author":"MC Assis","year":"2012","journal-title":"Med Oncol"},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1158\/1078-0432.CCR-04-1869","article-title":"Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells","volume":"11","author":"T Alvaro","year":"2005","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1158\/1078-0432.CCR-05-1886","article-title":"Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers","volume":"12","author":"C Badoual","year":"2006","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"issue":"6","key":"ref19","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1002\/ijc.30170","article-title":"Factors influencing survival among Kenyan children diagnosed with endemic Burkitt lymphoma between 2003 and 2011: A historical cohort study","volume":"139","author":"G Buckle","year":"2016","journal-title":"Int J Cancer"},{"issue":"6","key":"ref20","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/infdis\/jir872","article-title":"Early age at time of primary Epstein-Barr virus infection results in poorly controlled viral infection in infants from Western Kenya: clues to the etiology of endemic Burkitt lymphoma","volume":"205","author":"E Piriou","year":"2012","journal-title":"The Journal of infectious diseases"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0166-6851(93)90077-B","article-title":"High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction","volume":"61","author":"G Snounou","year":"1993","journal-title":"Mol Biochem Parasitol"},{"issue":"7","key":"ref22","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/ijc.24014","article-title":"Children with endemic Burkitt lymphoma are deficient in EBNA1-specific IFN-gamma T cell responses","volume":"124","author":"AM Moormann","year":"2009","journal-title":"Int J Cancer"},{"issue":"6186","key":"ref23","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.1254417","article-title":"Antibodies to PfSEA-1 block parasite egress from RBCs and protect against malaria infection","volume":"344","author":"DK Raj","year":"2014","journal-title":"Science"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2013.12.005","article-title":"Regulatory T cells in cancer immunotherapy","volume":"27","author":"H Nishikawa","year":"2014","journal-title":"Current opinion in immunology"},{"issue":"17","key":"ref25","doi-asserted-by":"crossref","first-page":"6659","DOI":"10.1073\/pnas.0509484103","article-title":"Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development","volume":"103","author":"MA Gavin","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"ref26","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.immuni.2009.03.019","article-title":"Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor","volume":"30","author":"M Miyara","year":"2009","journal-title":"Immunity"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/ijc.28378","article-title":"Sickle cell trait is not associated with endemic Burkitt lymphoma: an ethnicity and malaria endemicity-matched case-control study suggests factors controlling EBV may serve as a predictive biomarker for this pediatric cancer","volume":"134","author":"DH Mulama","year":"2014","journal-title":"Int J Cancer"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1200\/JCO.1989.7.2.186","article-title":"Non-Hodgkin's lymphomas of childhood: an analysis of the histology, staging, and response to treatment of 338 cases at a single institution","volume":"7","author":"SB Murphy","year":"1989","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1128\/JVI.02158-12","article-title":"Holoendemic malaria exposure is associated with altered Epstein-Barr virus-specific CD8(+) T-cell differentiation","volume":"87","author":"PK Chattopadhyay","year":"2013","journal-title":"J Virol"},{"issue":"6754","key":"ref30","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/44385","article-title":"Two subsets of memory T lymphocytes with distinct homing potentials and effector functions","volume":"401","author":"F Sallusto","year":"1999","journal-title":"Nature"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1146\/annurev.immunol.15.1.405","article-title":"Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection","volume":"15","author":"AB Rickinson","year":"1997","journal-title":"Annual review of immunology"},{"issue":"6","key":"ref32","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/bjh.12980","article-title":"Epstein-Barr virus infection induces an increase of T regulatory type 1 cells in Hodgkin lymphoma patients","volume":"166","author":"O Morales","year":"2014","journal-title":"Br J Haematol"},{"issue":"6230","key":"ref33","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1126\/science.aaa8172","article-title":"The future of immune checkpoint therapy","volume":"348","author":"P Sharma","year":"2015","journal-title":"Science"},{"issue":"5","key":"ref34","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00262-006-0225-8","article-title":"Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients","volume":"56","author":"F Ghiringhelli","year":"2007","journal-title":"Cancer immunology, immunotherapy: CII"},{"issue":"8","key":"ref35","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/nm.2883","article-title":"Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival","volume":"18","author":"S Walter","year":"2012","journal-title":"Nature medicine"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0167841","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T17:54:42Z","timestamp":1718992482000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0167841"}},"subtitle":[],"editor":[{"given":"Joseph S","family":"Pagano","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,12,29]]},"references-count":35,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,12,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0167841","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,29]]}}}